Elena Fercilien
Medical · Watkinsville, GANPI 1538636592
Payments from drug & device makers
Across 771 payments — averaging $92.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$39K
- Alkermes, Inc.$16K
- Idorsia Pharmaceuticals US Inc$5K
- AbbVie$2K
- Supernus Pharmaceuticals, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- plus $7K from 25 others
What the payments were for
- Consulting fees$17,36824%
- Speaking & faculty fees$34,99049%
- Travel & lodging$4,1866%
- Food & beverage$14,64621%
- Education$1350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 92 | $38,511 |
| Alkermes, Inc. | 92 | $16,443 |
| Idorsia Pharmaceuticals US Inc | 22 | $5,002 |
| AbbVie | 75 | $1,604 |
| Supernus Pharmaceuticals, Inc. | 82 | $1,410 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 68 | $1,173 |
| Johnson & Johnson | 32 | $766 |
| Lundbeck LLC | 35 | $706 |
| Otsuka America Pharmaceutical, Inc. | 26 | $618 |
| Vanda Pharmaceuticals Inc. | 23 | $601 |
| Teva Pharmaceuticals USA, Inc. | 36 | $569 |
| Corium, LLC | 14 | $503 |
| Tris Pharma Inc | 26 | $492 |
| Axsome Therapeutics, Inc. | 15 | $465 |
| Takeda Pharmaceuticals U.S.A., Inc. | 42 | $419 |
| Harmony Biosciences LLC | 8 | $289 |
| Noven Therapeutics, LLC | 17 | $247 |
| E.r. Squibb & Sons, L.L.C. | 6 | $237 |
| Eisai Inc. | 13 | $235 |
| Ironshore Pharmaceuticals Inc. | 9 | $207 |
| Sunovion Pharmaceuticals Inc. | 11 | $167 |
| Penumbra, Inc. | 1 | $151 |
| Indivior Inc. | 7 | $139 |
| Bausch Health US, LLC | 6 | $125 |
| Jazz Pharmaceuticals Inc. | 3 | $61 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Tempus AI, Inc | 2 | $39 |
| Adlon Therapeutics L.p. | 2 | $27 |
| Noven Pharmaceuticals, Inc. | 1 | $22 |
| OWP Pharmaceuticals, Inc. | 1 | $20 |
| Neuronetics, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$71,323 in reported general payments places this provider in the 95th percentile of 950 medical providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 42 | $387,005 |
| VraylarCariprazine Hcl | 38 | $60,491 |
| Abilify MaintenaAripiprazole | 16 | $36,862 |
| FanaptIloperidone | 24 | $34,151 |
| AuvelityDextromethorphan Hbr/Bupropion | 30 | $29,596 |
| RexultiBrexpiprazole | 11 | $22,882 |
| SecuadoAsenapine | 11 | $15,829 |
| Lurasidone Hcl | 41 | $12,461 |
| QuviviqDaridorexant Hcl | 24 | $12,013 |
| TrintellixVortioxetine Hydrobromide | 19 | $11,868 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 191 | $8,912 |
| Aripiprazole | 55 | $7,172 |
| DayvigoLemborexant | 19 | $6,415 |
| Ziprasidone Hcl | 54 | $6,001 |
| Paliperidone ErPaliperidone | 17 | $5,258 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $38,511 | $387,00542 claims |
| AbbVieVraylar | $1,604 | $60,49138 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $618 | $59,74427 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $601 | $34,15124 claims |
| Axsome Therapeutics, Inc.Auvelity | $465 | $29,59630 claims |
| Noven Pharmaceuticals, Inc.Secuado | $22 | $15,82911 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $5,002 | $12,01324 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $419 | $11,86819 claims |
| Eisai Inc.Dayvigo | $235 | $6,41519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 950 medical providers in Georgia.
Other medical in Watkinsville
- Michael BoydWatkinsville$42K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Felicia HoffmanRoswell$114K
- Sally BrumbillLithia Springs$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.